What’s Taking The NovoCure (NVCR) Stock Higher Today?
NovoCure Limited (NASDAQ: NVCR) shares are currently surging on the US market, having increased by 23.99% to $15.40 in the current session. The spike in NVCR stock value stems from a pivotal development in regulatory approval. The FDA (Food and Drug Administration) in the United States has accepted NovoCure’s Premarket Approval (PMA) application for review. […]
What’s Taking The NovoCure (NVCR) Stock Higher Today? Read More »